Hammoud Hospital University Medical Center
Saida 652
0 studies enrolling now · 14 studies all time
What they study most
Atrial Fibrillation, Complicated Urinary Tract Infection, Crohn's Disease, Deep Vein Thrombosis, First Line Non-Small Cell Lung Cancer, Lupus Erythematosus, Systemic, Lupus Nephritis, Pancreatic Cancer, Stroke, Ulcerative Colitis, Venous Thromboembolism
Studies at this site
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
- Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
- A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
- Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study — Completed
- Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) — Stopped early
- An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
- Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) — Stopped early
- Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism — Completed
- Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
- Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections — Completed
- Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early